You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SCT200

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)

Recruiting
  • Head and Neck Squamous Carcinoma
  • Shanghai, China
    Shanghai East Hospital
Sep 22, 2022

Esophageal Squamous Cell Carcinoma, Colorectal Cancer Trial (SCT-I10A, SCT200, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Colorectal Cancer
  • SCT-I10A
  • +2 more
  • (no location specified)
Jan 15, 2020

Hepatocellular Carcinoma Trial in Beijing (SCT-I10A, SCT510, Sorafenib 200mg)

Recruiting
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    307 Hospital of PLA
Nov 11, 2020

Advanced Squamous NSCLC Trial (SCT200)

Unknown status
  • Advanced Squamous Non-small Cell Lung Cancer
  • SCT200
  • (no location specified)
Jan 16, 2019

Esophageal Squamous Cell Carcinoma Trial in China (recombinant anti-EGFR mAb)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • recombinant anti-EGFR monoclonal antibody
  • Harbin, Heilongjiang, China
  • +3 more
Jan 24, 2019

Advanced Solid Tumors Trial in Beijing (SCT200)

Unknown status
  • Advanced Solid Tumors
  • SCT200
  • Beijing, Beijing, China
    307 Hospital of PLA
Sep 29, 2018

Triple Negative Breast Tumors Trial in Harbin (SCT200)

Unknown status
  • Triple Negative Breast Neoplasms
  • SCT200
  • Harbin, Heilongjiang, China
    Cancer Hospital Affiliated to Harbin Medical University
Sep 29, 2018

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

Not yet recruiting
  • Acute Myeloid Leukemia in Remission
  • Nantes, Loire Atlantique, France
  • +22 more
Jun 15, 2023

Hodgkin Lymphoma Trial (pembrolizumab)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • (no location specified)
May 30, 2022

Acute Myeloid Leukemia Trial in Italy (Venetoclax and Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax and Decitabine
  • San Giovanni Rotondo, Foggia, Italy
  • +24 more
Aug 8, 2022

Reliability of the "Gait Outcomes Assessment List"

Not yet recruiting
  • Rheumatologic Disease
  • +3 more
    • Istanbul, Turkey
      Istanbul University Medical Faculty Hospital
    Apr 27, 2023

    Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

    Not yet recruiting
    • Acute Leukemia
    • Rifaximin with allogeneic stem cell transplant
    • Allogeneic stem cell transplant
    • (no location specified)
    Sep 21, 2023

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Magrolimab
    • +3 more
    • Little Rock, Arkansas
    • +82 more
    Jan 17, 2023

    Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Basking Ridge, New Jersey
    • +9 more
    Jan 23, 2023

    Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

    Recruiting
    • Hodgkin Lymphoma
    • +3 more
    • Stanford, California
      Stanford University
    Jun 21, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Magrolimab
    • +6 more
    • Duarte, California
    • +25 more
    Feb 4, 2022

    Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

    Recruiting
    • Hematologic Neoplasms
    • Milan, Italy
      European Institute of Oncology
    Sep 24, 2021

    Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplasia
    • Oral azacitidine
    • Matched placebo
    • Birmingham, United Kingdom
    • +20 more
    Oct 14, 2021

    Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)

    Not yet recruiting
    • Hematologic Diseases
    • +2 more
    • haplo-SCT with PTCy
    • (no location specified)
    Nov 8, 2021

    Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

    Active, not recruiting
    • Testicular Cancer
    • Houston, Texas
    • +1 more
    Dec 5, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

    Recruiting
    • Leukemia, Myeloid, Acute
    • +5 more
    • Melbourne, Victoria, Australia
      Melbourne Health
    Jun 19, 2022

    Relapsed Childhood ALL, Relapsed Childhood Lymphoblastic Lymphoma Trial in Dallas (Venetoclax, Navitoclax)

    Available
    • Relapsed Childhood ALL
    • Relapsed Childhood Lymphoblastic Lymphoma
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Feb 28, 2022

    Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

    Recruiting
    • Hematologic Neoplasms
    • COVID-19 Vaccines
    • S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
    • +2 more
    • Vilnius, Lithuania
      Vilnius University Hospital Santaros Klinikos
    Dec 27, 2021